- Home
- VALU vs MRVI Comparison
VALU vs MRVI Comparison
Compare VALU & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VALU
- MRVI
- Stock Information
- Founded
- VALU 1931
- MRVI 2014
- Country
- VALU United States
- MRVI United States
- Employees
- VALU N/A
- MRVI N/A
- Industry
- VALU Investment Managers
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- VALU Finance
- MRVI Health Care
- Exchange
- VALU Nasdaq
- MRVI Nasdaq
- Market Cap
- VALU 345.7M
- MRVI 371.8M
- IPO Year
- VALU N/A
- MRVI 2020
- Fundamental
- Price
- VALU $37.90
- MRVI $2.33
- Analyst Decision
- VALU
- MRVI Hold
- Analyst Count
- VALU 0
- MRVI 10
- Target Price
- VALU N/A
- MRVI $5.84
- AVG Volume (30 Days)
- VALU 5.3K
- MRVI 1.5M
- Earning Date
- VALU 09-12-2025
- MRVI 08-11-2025
- Dividend Yield
- VALU 3.36%
- MRVI N/A
- EPS Growth
- VALU 8.91
- MRVI N/A
- EPS
- VALU 2.20
- MRVI N/A
- Revenue
- VALU $35,079,000.00
- MRVI $219,830,000.00
- Revenue This Year
- VALU N/A
- MRVI N/A
- Revenue Next Year
- VALU N/A
- MRVI $7.23
- P/E Ratio
- VALU $17.66
- MRVI N/A
- Revenue Growth
- VALU N/A
- MRVI N/A
- 52 Week Low
- VALU $32.94
- MRVI $1.67
- 52 Week High
- VALU $57.68
- MRVI $9.60
- Technical
- Relative Strength Index (RSI)
- VALU 48.80
- MRVI 45.75
- Support Level
- VALU $37.11
- MRVI $2.35
- Resistance Level
- VALU $38.85
- MRVI $2.51
- Average True Range (ATR)
- VALU 1.03
- MRVI 0.16
- MACD
- VALU 0.01
- MRVI -0.01
- Stochastic Oscillator
- VALU 58.46
- MRVI 39.87
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.